Factors | n = 121 |
---|---|
Age, years old | 61.1 ± 10.4 |
Male, n (%) | 64 (52.9) |
Longest pause, seconds | 5.4 ± 2.4 |
Time of AF symptom onset, months | 36.5 ± 32.3 |
Type of persistent AF, n (%) | 17 (14.0) |
AAD before procedure, n (%) | 77 (63.6) |
 Class I drug | 66 (54.5) |
 Class III drug | 11 (9.1) |
Antithrombotic drug, n (%) | 109 (90.1) |
 Warfarin | 45 (37.2) |
 Anti-platelet drug | 60 (49.6) |
 NOAC | 4 (3.3) |
LVEF | 57.8 ± 7.9 |
LA size, mm | 41.0 ± 5.6 |
E/e′ | 9.6 ± 5.2 |
Hypertension, n (%) | 66 (54.5) |
Diabetes mellitus, n (%) | 16 (13.2) |
CHAS2DS2-VASc score | 1.9 ± 1.3 |
 0, n (%) | 15 (12.4) |
 1, n (%) | 39 (32.2) |
 ≥ 2, n (%) | 67 (55.4) |
HAS-BLED score | 1.6 ± 1.1 |